Atlas Trials

Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)

Clinical trial NCT00400504 · UNKNOWN

Trial details

NCT number
NCT00400504
Sponsor
Rigshospitalet, Denmark
Status
UNKNOWN
Study type
OBSERVATIONAL
Cancer
Start date
2006-11-01
Enrollment
500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.